Perspectives of regulatory bodies on intellectual property for 3D-printed medical products
How does the European Patent Office (EPO) perceive patents for 3D-printed medical products?
Focusing on the European Patent Office's role, this academic paper explores the implications of 3D-printed medical products on intellectual property rights, particularly patents. It emphasizes the need for policymakers to adapt regulatory frameworks to address the unique challenges posed by emerging technologies like 3D-printing. The insights provided by the EPO can guide policymakers in identifying gaps in current legislation and understanding the regulatory needs for this innovative technology, ultimately enhancing legal certainty in the field.
